Willow Creek Capital Management, Inc.’s Gilead Sciences GILD Stock Holding History

Willow Creek Capital Management, Inc.’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$373K	Buy	+2,953	New	+$389K	0.36%	75

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Willow Creek Capital Management, Inc.'s GILD Position: Q2 2026 in Review

Willow Creek Capital Management, Inc. opened a new position in Gilead Sciences (GILD) in Q2 2026: 2,953 shares worth $373K. The stake represents 0.36% of the portfolio and ranks #75 among its holdings.

2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Willow Creek Capital Management, Inc. held 2,953 shares of Gilead Sciences worth $373K as of Q2 2026.
Gilead Sciences was a new Willow Creek Capital Management, Inc. position in Q2 2026.
Gilead Sciences made up 0.36% of Willow Creek Capital Management, Inc.'s portfolio in Q2 2026, its #75 holding.
2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Willow Creek Capital Management, Inc.'s 13F filing for Q2 2026, filed 8 Sep 2026.